SEARCH

PROVEN PROTECTION IN A SINGLE DOSE

It’s one of the most devastating and economically damaging pig diseases in the world: Porcine circovirus associated disease (PCVAD). It can strike early or appear in a late form. And once it strikes, the consequences are never good.
Protect your herd from wean to finish with the only single-dose circo vaccine for pigs three weeks of age or older: Ingelvac CircoFLEX® from Boehringer Ingelheim.

PCV2 CAN STRIKE AT ANY MOMENT

Pneumonia, PMWS, enteritis, respiratory disease, porcine dermatitis and nephropathy syndrome… those are just some of the diseases caused by PCV2 that can affect pigs suddenly if left unprotected. The result?

  • Dramatic increase in mortality
  • Increased number of lights
  • Increased cull rates
  • Substantial weight loss
  • Reduced profits

UNMATCHED SAFETY,1 UNPARALLELED TECHNOLOGY

  • Purified Circovirus Antigen (PCA™) is highly effective and safe to pigs, eliminating injection site reactions1,2
  • Highly syringeable, aqueous-based ImpranFLEX™ adjuvant is easy on pigs
  • Provides greater Pork Quality Assurance benefits

A SINGLE DOSE OF PROTECTION FROM WEAN
TO FINISH1

  • A single, 1 mL dose of Ingelvac CircoFLEX protects from 3 weeks through finishing
  • Option of vaccinating at weaning
  • Vaccinating at the youngest possible age (3 weeks) protects during early (nursery) and late (grow-finish) forms of disease

 


REDUCED MORTALITY AND CULLS, INCREASED ADG3

Field trials, laboratory studies and experience collected from over 100 million vaccinated pigs worldwide, prove the high level of efficacy against PCVAD.

In a controlled US field trial, pigs vaccinated at three weeks had a significant decrease in mortality. Average daily gain and final weights were also significantly higher than non-vaccinated pigs.3


SUBCLINICAL ROI: 5 to 1,4 CLINICAL ROI: 9 to 13

The economic benefits of Ingelvac CircoFLEX are easy to see, even in subclinical situations. Higher weight gains. Fewer culls. Reduced mortality. Better carcass traits. And the results are even more dramatic in clinical situations.

References
1.  Kolb, J., Diaz, E., AASV, March 2008.
2. Christmas, R., Kolb, J., Ingelvac CircoFLEX Symposium, September 2007, St. Paul, USA.
3.  Cline, G., Wilt, V., Diaz, E., Efficacy of Ingelvac CircoFLEX in pigs vaccinated at 3 and 6 weeks of age in a PRRS and Mycoplasma hyopneumoniae-negative production system, Leman Conference, 2007.
4.  Waddell, J., Field evaluation of Ingelvac CircoFLEX on growth performance of pigs in a subclinical PCVAD herd, World Pork Expo, 2009.